| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1999;99:2310-2316.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Is Correlated With Monocyte Infiltration in Mouse Lipid Lesions
From the Departments of Biochemistry and Medicine, University of Cambridge (UK) (J.R., J.C.M., D.J.G.), and Life Sciences Division, Lawrence Berkeley Laboratory, University of California, Berkeley (E.M.R., J.B.V.).
Correspondence to Jill Reckless, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Box 157, Hills Rd, Cambridge CB2 2QQ UK. E-mail jr219{at}mole.bio.cam.ac.uk
BackgroundApolipoprotein (apo)(a) transgenic mice and C57BL/6 mice fed a high fat diet develop similar-sized lipid lesions, but lesions in apo(a) mice are devoid of macrophages. We used this observation to identify which proinflammatory proteins might be involved in mediating monocyte recruitment during atherogenesis.
Methods and ResultsMacrophage-deficient apo(a)
transgenic mouse lesions contained similar levels of several different
proinflammatory proteins, both adhesion molecules (intercellular
adhesion molecule-1 [ICAM-1] and vascular cell adhesion molecule-1
[VCAM-1]) and cytokines (tumor necrosis factor-
[TNF-
] and macrophage inflammatory protein-1
[MIP-1
]), similar to the macrophage-rich lesions of
C57BL/6 mice.
ConclusionsFrom this we conclude that ICAM-1, VCAM-1, TNF-
,
and MIP-1
may all be necessary for vascular monocyte recruitment in
vivo, but they cannot be sufficient. Monocyte chemoattractant protein-1
(MCP-1) protein was undetectable in the vessel wall taken from apo(a)
transgenic mice fed a high fat diet compared with high expression in
mice with lipid lesions (C57BL/6 and apoE knockout mice). Therefore
elevated expression of MCP-1 but not TNF-
, MIP-1
, ICAM-1, or
VCAM-1 is correlated with vascular macrophage accumulation. To
test the hypothesis that monocyte infiltration during atherogenesis is
MCP-1 dependent, it will be necessary to develop specific
pharmacological inhibitors of MCP-1 activity.
Key Words: atherosclerosis monocytes aorta lipids lesion
This article has been cited by other articles:
![]() |
F. K. Swirski, M. J. Pittet, M. F. Kircher, E. Aikawa, F. A. Jaffer, P. Libby, and R. Weissleder Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease PNAS, July 5, 2006; 103(27): 10340 - 10345. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Korshunov, T. A. Nikonenko, V. A. Tkachuk, A. Brooks, and B. C. Berk Interleukin-18 and Macrophage Migration Inhibitory Factor Are Associated With Increased Carotid Intima-Media Thickening Arterioscler. Thromb. Vasc. Biol., February 1, 2006; 26(2): 295 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-H. Huang, L.-C. Chen, H.-B. Leu, P. Y.-A. Ding, J.-W. Chen, T.-C. Wu, and S.-J. Lin Enhanced Coronary Calcification Determined by Electron Beam CT Is Strongly Related to Endothelial Dysfunction in Patients With Suspected Coronary Artery Disease Chest, August 1, 2005; 128(2): 810 - 815. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Fries, R. Lightfoot, M. Koval, and H. Ischiropoulos Autologous Apoptotic Cell Engulfment Stimulates Chemokine Secretion by Vascular Smooth Muscle Cells Am. J. Pathol., August 1, 2005; 167(2): 345 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Waddington, I. B Puddey, and K. D Croft Red wine polyphenolic compounds inhibit atherosclerosis in apolipoprotein E-deficient mice independently of effects on lipid peroxidation Am. J. Clinical Nutrition, January 1, 2004; 79(1): 54 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Murphy, K. R. Bruckdorfer, D. C. Grimsditch, P. Overend, M. Vidgeon-Hart, P. H.E. Groot, G. M. Benson, and A. Graham Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1615 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamashita, S. Kawashima, M. Ozaki, M. Namiki, N. Inoue, K.-i. Hirata, and M. Yokoyama Propagermanium Reduces Atherosclerosis in Apolipoprotein E Knockout Mice via Inhibition of Macrophage Infiltration Arterioscler. Thromb. Vasc. Biol., June 1, 2002; 22(6): 969 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Schreyer, C. M. Vick, and R. C. LeBoeuf Loss of Lymphotoxin-alpha but Not Tumor Necrosis Factor-alpha Reduces Atherosclerosis in Mice J. Biol. Chem., March 29, 2002; 277(14): 12364 - 12368. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Koh, D. K. Jin, S. H. Yang, S.-K. Lee, H. Y. Hwang, M. H. Kang, W. Kim, D. S. Kim, I. S. Choi, and E. K. Shin Vascular Effects of Synthetic or Natural Progestagen Combined With Conjugated Equine Estrogen in Healthy Postmenopausal Women Circulation, April 17, 2001; 103(15): 1961 - 1966. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cipollone, M. Marini, M. Fazia, B. Pini, A. Iezzi, M. Reale, L. Paloscia, G. Materazzo, E. D'Annunzio, P. Conti, et al. Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 327 - 334. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-G. Lin, X.-Y. Yu, Y.-X. Chen, X. R. Huang, C. Metz, R. Bucala, C.-P. Lau, and H. Y. Lan De Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in Rabbits Circ. Res., December 8, 2000; 87(12): 1202 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Harnish, M. S. Scicchitano, S. J. Adelman, C. R. Lyttle, and S. K. Karathanasis The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-{kappa}B in HepG2 Cells Endocrinology, September 1, 2000; 141(9): 3403 - 3411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Evans, A. Eckert, K. Lai, S. J. Adelman, and D. C. Harnish Reciprocal Antagonism Between Estrogen Receptor and NF-{kappa}B Activity In Vivo Circ. Res., October 26, 2001; 89(9): 823 - 830. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |